Our fortnightly newsletter provides unparalleled data, insights and intelligence on the global psychedelics industry, straight to your inbox. Find the latest commercial deals, understand the latest regulatory changes and discover the most impactful scientific discoveries. Subscribe for free now.
Oregon psilocybin decriminalisation campaign and DC activists say they will qualify for the November ballot while the New Medical Psychedelics Working Group to lobby for ease in UK research restrictions. All this and more in Issue 1 of The Psychedelics Newsletter.
An attempt to block the Washington D.C. psychedelic initiative fails, therapists request approval to test psychedelics in Canada and Oregon gets set to vote on psilocybin for therapeutic use in November 2020.
Canada approves end-of-life psilocybin treatment for palliative patients while UK scientists and experts propose easing restrictions for medical psychedelics and Californian activists propose easing restrictions for medical psychedelics.
All this and more in Issue 3 of The Psychedelics Newsletter.
A petition to legalise natural psychedelics in Canada reaches 13,000 signatures, and a Congressman has said psychedelics show promise in treating PTSD as Oakland activists also unveil guidelines for psychedelic healing ceremonies.
All this and more in Issue 4 of The Psychedelics Newsletter.
THE LATEST INSIGHTS, STRAIGHT TO YOUR INBOX
Join industry insiders and subscribe for exclusive news, data and insights from across the psychedelics industry.
+44 (0) 203 928 2814
20-22 Wenlock Road, London, N1 7GU, United Kingdom